(Q37194776)

18 August 2017

1 reference

title

Advances in vaccination against tick-borne encephalitis (English)

1 reference

18 August 2017

Pamela Rendi-Wagner

1

1 reference

18 August 2017

publication date

1 July 2008

1 reference

Expert Review of Vaccines

18 August 2017

published in

1 reference

18 August 2017

volume

7

1 reference

18 August 2017

issue

5

1 reference

18 August 2017

page(s)

589-596

1 reference

Epidemiology and ecology of TBE relevant to the production of effective vaccines

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

TBE vaccination and the Austrian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

What makes ticks tick? Climate change, ticks, and tick-borne diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Socio-economic factors in the differential upsurge of tick-borne encephalitis in Central and Eastern Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Tick-borne virus diseases of human interest in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Tick-borne encephalitis complicated by a polio-like syndrome following a holiday in central Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Central European tick-borne encephalitis: assessment of risk for persons in the armed services and vacationers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Risk and prevention of tick-borne encephalitis in travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Molecular epidemiology of tick-borne encephalitis virus: cross-protection between European and Far Eastern subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

21 January 2018

History of TBE vaccines

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Protection against tick-borne encephalitis with a new vaccine formulation free of protein-derived stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Albumin is a necessary stabilizer of TBE-vaccine to avoid fever in children after vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN "NEW" in children: results of post-marketing surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Field effectiveness of vaccination against tick-borne encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Two severe cases of tick-borne encephalitis despite complete active vaccination--the significance of neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Tick-born encephalitis (TBE) vaccination in children: advantage of the rapid immunization schedule (i.e., days 0, 7, 21).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Antigen dependent adverse reactions and seroconversion of a tick-borne encephalitis vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

A controlled trial of tick-borne encephalitis vaccination in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

Capsid protein C of tick-borne encephalitis virus tolerates large internal deletions and is a favorable target for attenuation of virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

21 January 2018

Tick‐Borne Encephalitis

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.589

21 January 2018

Identifiers

DOI

10.1586/14760584.7.5.589

1 reference

18 August 2017

1 reference